William L. McGuire Memorial Symposium. The role and prognostic significance of p53 gene alterations in breast cancer.
Alterations in the p53 tumor suppressor gene are the most frequent genetic changes found in breast cancer, with an incidence reported in a range of 15 to 50%. The incidence of p53 alterations is approximately 15% for in situ carcinoma, while for invasive node-positive disease it is 2 to 3 times higher. This high rate of alteration suggests that the gene plays a central role in the development of breast cancer. The p53 gene functions as a negative regulator of cell growth. Alterations in the gene lead to loss of its usual negative growth regulation and more rapid cell proliferation. Since p53 alteration can reflect a more advanced state of progression and a higher rate of proliferation, breast tumors that have a p53 alteration could have a greater probability of having micrometastasis. p53 alterations could therefore be a prognostic factor for recurrence after primary local therapy. Consistent with this hypothesis, several independent studies using different methodologies have found that breast tumors with altered p53 have a worse prognosis and are also more likely to have other poor prognostic factors.
Elledge
R M
RM
Division of Medical Oncology, University of Texas Health Science Center, San Antonio 78284-7884.
Fuqua
S A
SA
Clark
G M
GM
Pujol
P
P
Allred
D C
DC
D000595:Amino Acid Sequence; D001483:Base Sequence; D001943:Breast Neoplasms / Q000235:genetics* / Q000401:mortality / Q000628:therapy; D002278:Carcinoma in Situ / Q000235:genetics; D002886:Chromosomes, Human, Pair 17; D005260:Female; D016368:Frameshift Mutation; D016158:Genes, p53; D006801:Humans; D009154:Mutation; D017354:Point Mutation; D011379:Prognosis; D017384:Sequence Deletion; D015996:Survival Rate